本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Fortress Biotech Inc Series A P

9.04
-0.3701-3.93%
盘后9.270.2300+2.54%16:00 EDT
成交量:2.68万
成交额:24.58万
市值:3,098.10万
市盈率:-4.12
高:9.67
开:9.58
低:8.85
收:9.41
52周最高:9.85
52周最低:4.72
股本:342.71万
流通股本:342.71万
量比:0.79
换手率:0.78%
股息:- -
股息率:- -
每股收益(TTM):-2.1959
每股收益(LYR):-2.6890
净资产收益率:-746.25%
总资产收益率:-32.37%
市净率:1.39
市盈率(LYR):-3.36

数据加载中...

2024/01/27

重要事件披露

Form 8-K - Current report
2024/01/03

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/01/03

重要事件披露

Form 8-K - Current report
2023/11/21

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/11/21

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/11/14

重要事件披露

Form 8-K - Current report
2023/11/14

重要事件披露

Form 8-K - Current report
2023/11/14

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/10/27

SEC问询函

Form CORRESP - Correspondence
2023/10/26

重要事件披露

Form 8-K - Current report
2023/10/11

重要事件披露

Form 8-K - Current report
2023/09/30

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2023/09/30

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2023/09/27

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/09/19

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/08/14

重要事件披露

Form 8-K - Current report
2023/08/14

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/07/19

SEC问询函

Form CORRESP - Correspondence
2023/07/06

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/06/23

重要事件披露

Form 8-K - Current report